Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 20

    1.

    Inactivation of high and low pathogenic avian influenza virus H5 subtypes by copper ions incorporated in zeolite-textile materials.

    Imai K, Ogawa H, Bui VN, Inoue H, Fukuda J, Ohba M, Yamamoto Y, Nakamura K.

    Antiviral Res. 2012 Feb;93(2):225-33. Epub 2011 Dec 9.

    PMID:
    22179064
    [PubMed - in process]
    2.

    Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A(H1N1)2009 virus infection in mice.

    Tarasov SA, Zarubaev VV, Gorbunov EA, Sergeeva SA, Epstein OI.

    Antiviral Res. 2012 Feb;93(2):219-24. Epub 2011 Dec 8.

    PMID:
    22178245
    [PubMed - in process]
    3.

    Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations.

    Gatwood J, Meltzer MI, Messonnier M, Ortega-Sanchez IR, Balkrishnan R, Prosser LA.

    Drugs. 2012 Jan 1;72(1):35-48. doi: 10.2165/11597310-000000000-00000. Review.

    PMID:
    22191794
    [PubMed - indexed for MEDLINE]
    4.

    Behaviour of influenza A viruses differentially expressing segment 2 gene products in vitro and in vivo.

    Tauber S, Ligertwood Y, Quigg-Nicol M, Dutia BM, Elliott RM.

    J Gen Virol. 2012 Apr;93(Pt 4):840-9. Epub 2011 Dec 21.

    PMID:
    22190016
    [PubMed - indexed for MEDLINE]
    5.

    Clarithromycin has limited effects in non-elderly, non-severe patients with seasonal influenza virus A infection.

    Ishii H, Komiya K, Yamagata E, Yatera K, Chojin Y, Yamamoto H, Mukae H, Kadota J.

    J Infect. 2012 Mar;64(3):343-5. Epub 2011 Dec 8. No abstract available.

    PMID:
    22178990
    [PubMed - in process]
    6.

    Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children.

    Iwane MK, Prill MM, Lu X, Miller EK, Edwards KM, Hall CB, Griffin MR, Staat MA, Anderson LJ, Williams JV, Weinberg GA, Ali A, Szilagyi PG, Zhu Y, Erdman DD.

    J Infect Dis. 2011 Dec;204(11):1702-10. Epub 2011 Oct 19.

    PMID:
    22013207
    [PubMed - indexed for MEDLINE]
    7.

    Nanobodies® specific for respiratory syncytial virus fusion protein protect against infection by inhibition of fusion.

    Schepens B, Ibañez LI, De Baets S, Hultberg A, Bogaert P, De Bleser P, Vervalle F, Verrips T, Melero J, Vandevelde W, Vanlandschoot P, Saelens X.

    J Infect Dis. 2011 Dec;204(11):1692-701. Epub 2011 Oct 12.

    PMID:
    21998474
    [PubMed - indexed for MEDLINE]
    8.

    Future opportunities for passive immunity against viral diseases.

    Graham BS.

    J Infect Dis. 2011 Dec;204(11):1648-50. Epub 2011 Oct 12. No abstract available.

    PMID:
    21998473
    [PubMed - indexed for MEDLINE]
    9.

    The receptor binding specificity of the live attenuated influenza H2 and H6 vaccine viruses contributes to vaccine immunogenicity and protection in ferrets.

    Chen Z, Zhou H, Kim L, Jin H.

    J Virol. 2012 Mar;86(5):2780-6. Epub 2011 Dec 21.

    PMID:
    22190726
    [PubMed - indexed for MEDLINE]
    10.

    Molecular signatures associated with Mx1-mediated resistance to highly pathogenic influenza virus infection: mechanisms of survival.

    Cilloniz C, Pantin-Jackwood MJ, Ni C, Carter VS, Korth MJ, Swayne DE, Tumpey TM, Katze MG.

    J Virol. 2012 Mar;86(5):2437-46. Epub 2011 Dec 21.

    PMID:
    22190720
    [PubMed - indexed for MEDLINE]
    11.

    Identification of host genes linked with the survivability of chickens infected with recombinant viruses possessing H5N1 surface antigens from a highly pathogenic avian influenza virus.

    Uchida Y, Watanabe C, Takemae N, Hayashi T, Oka T, Ito T, Saito T.

    J Virol. 2012 Mar;86(5):2686-95. Epub 2011 Dec 21. Erratum in: J Virol. 2012 Apr;86(8):4719.

    PMID:
    22190712
    [PubMed - indexed for MEDLINE]
    12.

    Safety and immunogenicity of an MF59(®)-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly.

    Vesikari T, Forstén A, Herbinger KH, Cioppa GD, Beygo J, Borkowski A, Groth N, Bennati M, von Sonnenburg F.

    Vaccine. 2012 Feb 8;30(7):1388-96. Epub 2011 Dec 20.

    PMID:
    22192847
    [PubMed - in process]
    13.

    Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales.

    Pitman RJ, White LJ, Sculpher M.

    Vaccine. 2012 Feb 1;30(6):1208-24. Epub 2011 Dec 13.

    PMID:
    22178725
    [PubMed - indexed for MEDLINE]
    14.

    Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: results from a cohort study in general practice.

    Hardelid P, Fleming DM, Andrews N, Barley M, Durnall H, Mangtani P, Pebody R.

    Vaccine. 2012 Feb 8;30(7):1371-8. Epub 2011 Dec 16.

    PMID:
    22178524
    [PubMed - in process]
    15.

    Influenza vaccination coverage one year after the A(H1N1) influenza pandemic, France, 2010-2011.

    Guthmann JP, Fonteneau L, Bonmarin I, Lévy-Bruhl D.

    Vaccine. 2012 Feb 1;30(6):995-7. Epub 2011 Dec 15.

    PMID:
    22178520
    [PubMed - indexed for MEDLINE]
    16.

    Prevaccination antibody titers can estimate the immune response to influenza vaccine in a rural community-dwelling elderly population.

    Matsushita M, Takeuchi S, Kumagai N, Uehara Y, Matsushita C, Arise K, Seo H, Awatani T.

    Vaccine. 2012 Feb 1;30(6):1101-7. Epub 2011 Dec 15.

    PMID:
    22178518
    [PubMed - indexed for MEDLINE]
    17.

    Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients.

    Lertdumrongluk P, Changsirikulchai S, Limkunakul C, Prachukthum P, Punpiput P, Buppanharun R, Chotpitayasunondh C.

    Vaccine. 2012 Feb 1;30(6):1108-14. Epub 2011 Dec 15.

    PMID:
    22178515
    [PubMed - indexed for MEDLINE]
    18.

    Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children.

    Karron RA, Thumar B, Schappell E, Surman S, Murphy BR, Collins PL, Schmidt AC.

    Vaccine. 2012 Jun 6;30(26):3975-81. Epub 2011 Dec 14.

    PMID:
    22178099
    [PubMed - in process]
    19.

    Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: a pilot study.

    Carraro G, Naso A, Montomoli E, Gasparini R, Camerini R, Panatto D, Tineo MC, De Giorgi L, Piccirella S, Khadang B, Ceracchi M, De Rosa A.

    Vaccine. 2012 Feb 1;30(6):1170-80. Epub 2011 Dec 14.

    PMID:
    22178096
    [PubMed - indexed for MEDLINE]
    20.

    H4N8 subtype avian influenza virus isolated from shorebirds contains a unique PB1 gene and causes severe respiratory disease in mice.

    Bui VN, Ogawa H, Xininigen, Karibe K, Matsuo K, Awad SS, Minoungou GL, Yoden S, Haneda H, Ngo LH, Tamaki S, Yamamoto Y, Nakamura K, Saito K, Watanabe Y, Runstadler J, Huettmann F, Happ GM, Imai K.

    Virology. 2012 Feb 5;423(1):77-88. Epub 2011 Dec 20. Erratum in: Virology. 2012 Apr 25;426(1):83-5. Huettman, Falk [corrected to Huettmann, Falk].

    PMID:
    22192630
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk